256 related articles for article (PubMed ID: 31205032)
1. Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases.
Panigrahy D; Gartung A; Yang J; Yang H; Gilligan MM; Sulciner ML; Bhasin SS; Bielenberg DR; Chang J; Schmidt BA; Piwowarski J; Fishbein A; Soler-Ferran D; Sparks MA; Staffa SJ; Sukhatme V; Hammock BD; Kieran MW; Huang S; Bhasin M; Serhan CN; Sukhatme VP
J Clin Invest; 2019 Jun; 129(7):2964-2979. PubMed ID: 31205032
[TBL] [Abstract][Full Text] [Related]
2. Dampening the fire to prevent surgery- and chemotherapy-induced metastasis.
Güç E; Pollard JW
J Clin Invest; 2019 Jun; 129(7):2663-2665. PubMed ID: 31205029
[TBL] [Abstract][Full Text] [Related]
3. Resolvins suppress tumor growth and enhance cancer therapy.
Sulciner ML; Serhan CN; Gilligan MM; Mudge DK; Chang J; Gartung A; Lehner KA; Bielenberg DR; Schmidt B; Dalli J; Greene ER; Gus-Brautbar Y; Piwowarski J; Mammoto T; Zurakowski D; Perretti M; Sukhatme VP; Kaipainen A; Kieran MW; Huang S; Panigrahy D
J Exp Med; 2018 Jan; 215(1):115-140. PubMed ID: 29191914
[TBL] [Abstract][Full Text] [Related]
4. Aspirin-triggered proresolving mediators stimulate resolution in cancer.
Gilligan MM; Gartung A; Sulciner ML; Norris PC; Sukhatme VP; Bielenberg DR; Huang S; Kieran MW; Serhan CN; Panigrahy D
Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6292-6297. PubMed ID: 30862734
[TBL] [Abstract][Full Text] [Related]
5. Postoperative administration of ketorolac averts morphine-induced angiogenesis and metastasis in triple-negative breast cancer.
Liu Z; Cheng S; Fu G; Ji F; Wang C; Cao M
Life Sci; 2020 Jun; 251():117604. PubMed ID: 32243929
[TBL] [Abstract][Full Text] [Related]
6. Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses.
Chiurchiù V; Leuti A; Dalli J; Jacobsson A; Battistini L; Maccarrone M; Serhan CN
Sci Transl Med; 2016 Aug; 8(353):353ra111. PubMed ID: 27559094
[TBL] [Abstract][Full Text] [Related]
7. D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization.
Pope NH; Salmon M; Davis JP; Chatterjee A; Su G; Conte MS; Ailawadi G; Upchurch GR
FASEB J; 2016 Dec; 30(12):4192-4201. PubMed ID: 27619672
[TBL] [Abstract][Full Text] [Related]
8. Morphine-sparing effect by COX-1 inhibitor sustains analgesic function without compromising antigen-specific immunity and antitumor effect of naked DNA vaccine.
Sun WZ; Chang MC; Hsiao PN; Chen CA; Hsu YT; Hsieh CY; Cheng WF
Int J Immunopathol Pharmacol; 2010; 23(1):91-104. PubMed ID: 20377998
[TBL] [Abstract][Full Text] [Related]
9. Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome.
Lopategi A; Flores-Costa R; Rius B; López-Vicario C; Alcaraz-Quiles J; Titos E; Clària J
J Leukoc Biol; 2019 Jan; 105(1):25-36. PubMed ID: 29601102
[TBL] [Abstract][Full Text] [Related]
10. Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation.
Zhang MJ; Sansbury BE; Hellmann J; Baker JF; Guo L; Parmer CM; Prenner JC; Conklin DJ; Bhatnagar A; Creager MA; Spite M
Circulation; 2016 Aug; 134(9):666-680. PubMed ID: 27507404
[TBL] [Abstract][Full Text] [Related]
11. NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup.
Retsky M; Rogers R; Demicheli R; Hrushesky WJ; Gukas I; Vaidya JS; Baum M; Forget P; Dekock M; Pachmann K
Breast Cancer Res Treat; 2012 Jul; 134(2):881-8. PubMed ID: 22622810
[TBL] [Abstract][Full Text] [Related]
12. Nanoscale Reduced Graphene Oxide-Mediated Photothermal Therapy Together with IDO Inhibition and PD-L1 Blockade Synergistically Promote Antitumor Immunity.
Yan M; Liu Y; Zhu X; Wang X; Liu L; Sun H; Wang C; Kong D; Ma G
ACS Appl Mater Interfaces; 2019 Jan; 11(2):1876-1885. PubMed ID: 30582788
[TBL] [Abstract][Full Text] [Related]
13. Novel Resolvin D2 Receptor Axis in Infectious Inflammation.
Chiang N; de la Rosa X; Libreros S; Serhan CN
J Immunol; 2017 Jan; 198(2):842-851. PubMed ID: 27994074
[TBL] [Abstract][Full Text] [Related]
14. Resolvin D2 Restrains Th1 Immunity and Prevents Alveolar Bone Loss in Murine Periodontitis.
Mizraji G; Heyman O; Van Dyke TE; Wilensky A
Front Immunol; 2018; 9():785. PubMed ID: 29922275
[TBL] [Abstract][Full Text] [Related]
15. Perioperative neutrophil:lymphocyte ratio and postoperative NSAID use as predictors of survival after lung cancer surgery: a retrospective study.
Choi JE; Villarreal J; Lasala J; Gottumukkala V; Mehran RJ; Rice D; Yu J; Feng L; Cata JP
Cancer Med; 2015 Jun; 4(6):825-33. PubMed ID: 25756351
[TBL] [Abstract][Full Text] [Related]
16. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation.
Mas E; Croft KD; Zahra P; Barden A; Mori TA
Clin Chem; 2012 Oct; 58(10):1476-84. PubMed ID: 22912397
[TBL] [Abstract][Full Text] [Related]
17. Potential Benefit of Intra-operative Administration of Ketorolac on Breast Cancer Recurrence According to the Patient's Body Mass Index.
Desmedt C; Demicheli R; Fornili M; Bachir I; Duca M; Viglietti G; Berlière M; Piccart M; Sotiriou C; Sosnowski M; Forget P; Biganzoli E
J Natl Cancer Inst; 2018 Oct; 110(10):1115-1122. PubMed ID: 29718396
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery.
Forget P; Machiels JP; Coulie PG; Berliere M; Poncelet AJ; Tombal B; Stainier A; Legrand C; Canon JL; Kremer Y; De Kock M
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S650-60. PubMed ID: 23884751
[TBL] [Abstract][Full Text] [Related]
19. Proinflammatory actions of thromboxane receptors to enhance cellular immune responses.
Thomas DW; Rocha PN; Nataraj C; Robinson LA; Spurney RF; Koller BH; Coffman TM
J Immunol; 2003 Dec; 171(12):6389-95. PubMed ID: 14662837
[TBL] [Abstract][Full Text] [Related]
20. Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling.
Elajami TK; Colas RA; Dalli J; Chiang N; Serhan CN; Welty FK
FASEB J; 2016 Aug; 30(8):2792-801. PubMed ID: 27121596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
